Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions.

Janne, PA; Neal, JW; Camidge, DR; Spira, AI; Piotrowska, Z; Horn, L; Costa, DB; Tsao, AS; Patel, JD; Gadgeel, SM; Bazhenova, L; Zhu, VW; West, H; Vincent, S; Zhu, J; Li, SL; Riely, GJ

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索